ST. LOUIS, Sept. 9, 2019 /PRNewswire/ -- Pharmspective LLC announced today the introduction of HealthPlanView™, the first visual analytics platform built to assess the true drug cost burden to patients and payers.

MARLBOROUGH, Mass., Sept. 9, 2019 /PRNewswire/ -- Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (sd-rxRNA®) therapeutic platform, announced today that it has entered into a research collaboration with Carisma Therapeutics to evaluate the p

JERUSALEM, Sept. 9, 2019 /PRNewswire/ -- KAHR Medical, a biopharmaceutical company developing a novel drug platform based on bi-functional, immunotherapeutic fusion proteins known as DSP (Dual Signaling Proteins), announced today a new clinical collaboration with Roche. The collaboration will explore KAHR's lead program, DSP107, a SIRPα-41

DUBLIN, Sept. 9, 2019 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced initial results, including positive biomarker responses, from its Phase 1 single-ascending dose (SAD) and multiple-ascending dose (MAD) clinical trial of TD-8236, an investigational, lung-selective inhaled pan-Janus kinase (JAK) i

MONMOUTH JUNCTION, N.J., Sept. 9, 2019 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its

LONDON and PHILADELPHIA, Sept. 9, 2019 /PRNewswire/ -- Clarivate Analytics plc (NYSE:CCC;CCC.WS), a global leader in providing trusted insights and analytics to accelerate the pace of innovation, today announce

PHILADELPHIA, Sept. 9, 2019 /PRNewswire/ -- EIR Healthcare, the modular innovation firm bringing efficient industrial practices to healthcare, real estate and hospitality, is excited to annou

REHOVOT, Israel, Sept. 9, 2019 /PRNewswire/ -- CollPlant (NASDAQ:CLGN) (the "Company"), a regenerative medicine company, announced it has closed on a total of $5.5 million in convertible loans. A group of U.S. accredited investors with deep experience in the 3D printing industry purchased $3.5 millio

WARSAW, Ind., Sept. 9, 2019 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced FDA 510(k) clearance for the Persona® Revision Knee System for revision knee replacement procedures. The Company expects to launch the system for patients in the United States

MINNEAPOLIS, Sept. 9, 2019 /PRNewswire/ -- The Emily Program, a national leader in eating disorder treatment, opened the doors of its new 16-bed